Reducing collateral damage to excised tissue: Surgeons study device using radiofrequency energy
December 06, 2015
Blair and colleagues published survey results in the November 2009 edition of the Journal of the American College of Surgeons highlighting a wide variety of practice patterns in the US for handling surgical margins in breast conservation treatment. The paper called for additional study of treatments to examine the minimal amount of surgical treatment necessary in conjunction with chemotherapy and radiation to better control cancer rates.
According to the Centers for Disease Control and Prevention, breast cancer is the most common form of cancer in women aside from non-melanoma skin malignancies. Breast cancer is the number one cause of cancer death in Hispanic women. It is the second most common cause of cancer death in white, black, Asian/Pacific Islander, and American Indian/Alaska Native women.
This IRB- approved clinical trial to evaluate surgical excision margins in malignant breast lumpectomies is sponsored by PEAK Surgical, Inc.
Source Moores UCSD Cancer Center